Malaria during pregnancy is caused when parasite-infected erythrocytes accumulate within the placenta through interactions between the VAR2CSA protein on the infected erythrocyte surface and placental CSPGs (chondroitin sulfate proteoglycans). This interaction is the major target for therapeutics to treat or prevent pregnancy-associated malaria. Here we review the structural characterization of CSPG-binding DBL (Duffy-binding like) domains from VAR2CSA and summarize the growing evidence that the exquisite ligand specificity of VAR2CSA results from the adoption of higher-order architecture in which these domains fold together to form a ligand-binding pocket.
phenotype that is specific to infected erythrocytes taken from pregnant women [10] . This interaction is highly specific to 4-sulfated chondroitin structures with little or no binding to other glycosaminoglycan carbohydrates [10] [11] [12] [13] . The interaction is also affected by the percentage of sulfation of the CSPG, with the highest efficacy coming from a combination of unsulfated and 4-sulfated disaccharides [14, 15] .
The adhesive properties of infected erythrocytes are caused by parasite proteins of the PfEMP1 (P. falciparum erythrocyte membrane protein 1) family. These are exported to the membranes of infected erythrocytes where they cause sequestration by interacting with human receptors. Although PfEMP1 proteins vary significantly in size and sequence, they share a common modular architecture with a C-terminal intracellular domain, a single transmembrane helix and an extracellular ectodomain consisting of multiple DBL (Duffybinding like) domains and CIDRs (cysteine-rich interdomain regions) [16, 17] . Different PfEMP1 proteins interact with a wide range of different human receptors, with CD36-and ICAM-1 (intercellular adhesion molecule 1)-binding phenotypes among the most common [18] [19] [20] . These binding properties have been mapped to individual DBL domains or CIDRs [21, 22] , leading to the suggestion that individual domains contribute discrete ligand-binding sites to their PfEMP1 ectodomain in a modular and combinatorial fashion [23] .
A single PfEMP1 protein, VAR2CSA, is implicated as the adhesion receptor in placental malaria [8, 24, 25] . VAR2CSA is up-regulated in parasite strains taken from pregnant women [26] and deletion of its gene prevents the development of a specific CSPG-binding phenotype [27, 28] . The immunity that develops following multiple pregnancies is associated with antibodies that bind to VAR2CSA protein [26] and block CSA binding [29] [30] [31] . Indeed, antibodies raised against different fragments of the VAR2CSA ectodomain reduce the binding of infected erythrocytes to CSA [32] [33] [34] [35] . This suggests that the interaction between VAR2CSA and CSPG is the principle target for the development of therapeutics to target placental malaria.
Diverse CSPG-binding surfaces on VAR2CSA DBL domains
The VAR2CSA ectodomain consists of six DBL domains, together with significant interdomain regions ( Figure 1A ). These DBL domains have each been expressed and four have been shown to bind to CSPG [36] [37] [38] . The first structural studies of VAR2CSA characterized the crystal structures of two of these domains and mapped their CSPG-binding surfaces.
The structure of the DBL3X domain was independently solved in two different laboratories [39, 40] . It has an α-helical scaffold similar to that observed in DBL domains from the invasion proteins, EBA-175 (erythrocyte-binding antigen 175) and the DARC (Duffy antigen/receptor for chemokines)-binding protein [41, 42] , but is decorated with many complex loop insertions. A loop on the concave face of the domain, residues 1323-1334, drew particular attention [39] . While this is disordered in the structure of DBL3X alone, it becomes structured when the domain interacts with sulfate ions or carbohydrate fragments ( Figure 1B ). This forms a sulfate-binding site and completes the major patch of positive charge on the domain surface [39] . With the exception of a lysine residue involved in formation of the sulfate-binding site, this loop is polymorphic and under diversifying selection pressure, as expected for a region of the protein exposed to the immune system [37, 43] . It is also the target of antibodies from both multigravid pregnant women [37] and inhibitory sera from immunized rats [34] .
A second structure of DBL3X, solved in the presence of longer carbohydrate fragments, showed diffuse density attributed to carbohydrate in the region of this positively charged patch [40] and mutagenesis confirmed that residues in both the sulfate-binding pocket and positively charged patch are involved in the interaction between CSPG and DBL3X in vitro [40, 44] . These structures suggested a model for CSPG binding by DBL3X in which a polymorphic loop on the exposed face of the domain becomes ordered on binding to a sulfate ion from CSPG, leading to the completion of the CSPG-binding site [39] .
A structure of the DBL6ε domain shows a similar architecture to DBL3X with a helical scaffold decorated with loops [44] . However, there are significant differences. The loops of DBL6ε are shorter, in particular with the sulfate-binding loop of DBL3X replaced by a tight turn ( Figure 1C ). In addition, the positively charged patch which forms the CSPG-binding site of DBL3X is missing from DBL6ε. Instead, positively charged residues on a different face of the domain form the CSPG-binding surface [44] . These residues are on a surface that is recognized by immune sera and therefore surface-exposed in the intact protein [45] . These studies show that the CSPG-binding DBL domains from VAR2CSA contribute different surface features, including positively charged patches and sulfatebinding sites, which combine to mediate the interaction with CSPG.
CSPG-binding specificity requires multiple domains
A distinctive feature of VAR2CSA-expressing infected erythrocytes is their high carbohydrate-binding specificity. While these cells bind tightly to 4-sulfated chondroitin structures such as CSPG, they do not interact with other glycosaminoglycan carbohydrates [10] [11] [12] [13] [14] . In contrast, individual VAR2CSA domains bind promiscuously, with the binding affinity increasing with the negative charge of the carbohydrate molecule [38, 44] . This led to questions about the role of VAR2CSA in CSPG binding, and whether additional molecules are needed on the infected erythrocyte surface to provide specificity.
Two recent studies have investigated these questions using intact VAR2CSA ectodomain expressed in eukaryotic systems [35, 46] . While the individual DBL3X and DBL6ε domains bind to CSPG with affinities in the midmicromolar range, these intact ectodomains bind with a low nanomolar affinity. In addition, they show high specificity, with CSPG and CSA interacting tightly, whereas other glycosaminoglycan carbohydrates bind significantly more weakly. Therefore the VAR2CSA ectodomain does contain the determinants needed for specific CSPG binding and this binding site requires more than single DBL domains.
Does the VAR2CSA ectodomain adopt higher-order architecture?
These studies show that the high-affinity CPSG-specific binding properties of the VAR2CSA ectodomain result from the combination of multiple low-affinity non-specific binding sites contributed by individual domains. Although increased affinity could result simply from avidity increases mediated by joining single domains through flexible linkers, multiple lines of evidence suggest a more complex model in which VAR2CSA adopts a higher-order architecture.
First, the specificity of the intact ectodomain matches that of VAR2CSA-expressing infected erythrocytes with highaffinity binding to 4-sulfated chondroitin structures and little interaction with other closely related glycosaminoglycan carbohydrates [35, 46] . Even 6-sulfated chondroitin sulfate C, which differs from CSPG only in the position of the sulfate group of the N-acetylgalactosamine moiety, shows little or no binding to the ectodomain. It is hard to envisage how joining the CSPG-binding sites of the DBL3X and DBL6ε domains through flexible tethers could generate such exquisite specificity. Instead, it seems likely that higher-order structure positions the binding sites contributed by individual domains to form a specific binding pocket.
Bioinformatic studies of the VAR2CSA ectodomain support the idea of higher-order architecture. Structure is predicted in some of the interdomain regions, with interdomain 2 in particular proposed to adopt a helical structure similar to that of a CIDR domain [45] . The IUPred [47] and PONDR [48] algorithms also predict the entire ectodomain to adopt an ordered structure, with short disordered regions as prevalent within the DBL domains as in the interdomain regions. Low-resolution structural studies of intact ectodomain support this view. Analytical ultracentrifugation shows the ectodomain to be monomeric with hydrodynamic properties consistent with a compact structure [35, 46] . Small-angle X-ray scattering also reveals a folded, monomeric structure significantly more compact than expected from a flexible linear chain of domains [35] .
Further evidence comes from analysis of the distribution of polymorphic regions in the VAR2CSA ectodomain. The comparison of sequences of VAR2CSA taken from parasites from diverse geographical locations allows identification of conserved and polymorphic regions of the protein [37, 43] . The polymorphic regions are under diversifying selection pressure owing to exposure to the immune system, whereas the conserved invariant regions are thought not to be accessible to immune detection.
Plotting polymorphic residues on to the structure of the DBL3X domain showed them to cluster on a single face, whereas a large proportion of the domain surface is conserved [39] . The predictions are similar for each of the first five DBL domains [43] . In addition, many of the interdomain regions have large invariant parts, with some, such as interdomains 2 and 4, showing a pattern of variant and invariant residues, whereas interdomain 3 is mostly invariant [43] . These patterns would not be expected if VAR2CSA consisted of a string of individual domains attached through flexible linkers. Instead, they suggest that much of the surfaces of the DBL domains, and the interdomain regions, are concealed from the immune response through packing together as part of higher-order architecture, leaving only restricted regions of the ectodomain surface exposed to the immune system and under diversifying selection pressure.
Finally, antibodies have been raised against many of the individual domains from VAR2CSA and tested for the ability to prevent the interaction between VAR2CSA-expressing infected erythrocytes and CSPG. Antibodies raised against DBL domains 1, 3, 4 or 6 can show some inhibitory activity [32] [33] [34] , with the highest level of inhibition for those which bind to DBL4 [33] . As DBL4 is one of only two domains from VAR2CSA that has not been identified as a CSPGbinding domain these findings are surprising! The most likely explanation is that the higher-order architecture of the VAR2CSA ectodomain brings DBL4 into close proximity to the CSPG-binding pocket such that the binding of antibodies is able to occlude access to this pocket. Future structural studies will characterize the precise nature of this higherorder organization.
Is VAR2CSA unique?
Owing to its role as the central protein in pregnancyassociated malaria, VAR2CSA is the most closely studied member of the PfEMP1 family. These studies are changing the way in which we view the PfEMP1 proteins as the model of PfEMP1s as chains of discrete ligand-binding domains does not account for the binding properties of the VAR2CSA ectodomain. Whether this is unique for VAR2CSA or a general feature of PfEMP1 protein function is an ongoing question. VAR2CSA is certainly unusual. Although the majority of PfEMP1 proteins start with a conserved DBL-CIDR head structure followed by combinations of CIDR and DBL domains, VAR2CSA consists entirely of DBL domains with long interdomain regions [16, 17] . VAR2CSA also shows more sequence conservation than other PfEMP1 proteins and undergoes restricted recombination with other var genes [17, 49] . It is the only PfEMP1 protein found in all of the 3D7, IT and HB4 strains [17] . To show whether it is unique, or whether higher-order architecture is the norm, will require more detailed analysis of the binding properties and structures of other PfEMP1 proteins. In the meantime, detailed characterization of VAR2CSA and its interaction with its ligand will continue as part of the attempts to develop therapeutics to treat malaria during pregnancy. 
